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ABSTRAK
Diabetes mellitus (DM) adalah kelainan metabolik kompleks dan kronis yang menyebabkan banyak 
komplikasi. Salah satu komplikasi DM yang paling umum adalah neuropati diabetes. Ada banyak penelitian 
yang mengeksplorasi sensitivitas kornea sebagai penanda potensial neuropati diabetes. Artikel ini bertujuan 
untuk mengeksplorasi hubungan antara sensitivitas kornea dan neuropati diabetes. Pada neuropati diabetes, 
sensitivitas kornea terganggu akibat rendahnya tingkat faktor trofik saraf kornea, serabut saraf sensorik 
terganggu, dan kehilangan komunikasi sel dendtritik. Pada pasien diabetes, kondisi ini dapat dinilai dengan 
beberapa teknik, seperti estetika Cochet Bonnet, aesthesiometri kornea non-kontak, dan mikroskop konfokal. 
Beberapa target terapeutik yang menjanjikan untuk sensitivitas kornea terganggu meliputi terapi faktor sel induk 
dan pertumbuhan yang dapat digunakan untuk mencegah komplikasi pada pasien dengan keratopati neurotropika 
diabetes. Sensitivitas kornea yang terganggu berperan sebagai penanda potensial neuropati diabetes. Dokter, 
dokter mata dan ahli penyakit dalam, harus mengantisipasi kemungkinan untuk mengamati perubahan berikut 
pada pasien diabetes dengan neuropati dengan menggunakan uji penilaian sensitivitas kornea.
Kata kunci: diabetes melitus, diabetik neuropati, sensitivitas kornea, uji penilaian.
ABSTRACT
Diabetes mellitus (DM) is a complex and chronic metabolic disorder leading to many complications. One 
of the most common complications of DM is diabetic neuropathy. There are many studies exploring corneal 
sensitivity as a potential marker of diabetic neuropathy. This review aims to explore association between corneal 
sensitivity and diabetic neuropathy. In diabetic neuropathy, corneal sensitivity is impaired due to low level 
of corneal nerve trophic factors, impaired sensory nerve fibers, and lost communication of dendtritic cell. In 
diabetic patients, this condition can be assessed by several techniques, such as Cochet Bonnet aesthesiometry, 
non-contact corneal aesthesiometry, and confocal microscopy. Few promising therapeutic targets for impaired 
corneal sensitivity include stem cell and growth factor therapy that can be used to prevent complication in patient 
with diabetic neurotrophic keratopathy. Impaired corneal sensitivity serve as a potential marker of diabetic 
neuropathy. Doctors, opthalmologists and internists, should anticipate the possibility of observing the following 
changes in diabetic patients with neuropathy by using corneal sensitivity assessment test.
Keywords: diabetes mellitus, diabetic neuropathy, corneal sensitivity, assessment test.
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INTRODUCTION
Diabetes mellitus (DM) is a complex and 
chronic metabolic disorder that can lead to death 
if not managed properly. It is estimated that 415 
million (8.8%) adults in the world are living with 
diabetes in 2015 and this prevalence is predicted 
to grow to 642 million in the next 25 years.1
DM can lead to many debilitating acute 
and chronic complications, which include 
neuropathy, retinopathy, nephropathy, stroke, 
and myocardial infarction.2 Diabetic neuropathy 
(DN) is the most common complication of DM, 
affecting 50% patients.1 Early diagnosis of 
neuropathy in diabetic patient is important for 
risks evaluation and therapeutic management 
thus preventing complications. Recently, there 
are many studies exploring corneal sensitivity 
as a potential marker of diabetic neuropathy.3,4 
Corneal innervation has higher density than skin 
or others and the assesment are not invasive nor 
difficult. This review aims to explore recent 
studies about association between corneal 
sensitivity and diabetic peripheral neuropathy.
DIABETES MELLITUS
DM is a metabolic disorder which is caused 
by multiple etiologies. The main characteristic of 
DM is chronic hyperglycemia with disturbances 
of carbohydrate, fat, and protein metabolism 
due to inadequate insulin secretion, action, 
or both.4 Microvascular and macrovascular 
complications are the pathologic hallmark of 
DM. It provokes changes in blood vessels by 
affecting the capillary basement membrane 
including arterioles in the glomeruli, retina, skin, 
muscle, myocardium.1 Several complications that 
are included as acute complications are diabetic 
ketoacidosis, hyperosmolar hyperglycemic 
states, lactic acidosis, and hypoglycemia. If 
they are not treated immediately, death can 
occur.2 Chronic complications of DM include 
diabetic nephropathy, atherosclerosis, diabetic 
retinopathy, and DN. As an organ with rich 
vascularization, the eyes are also one of the 
targets of these DM complications.1,2,5
DM and its associated ocular diseases 
encompass a complicated disorder with multiple 
etiologies, both genetic and environmental 
factors. Diabetic retinopathy is the most common 
ocular diseases related to DM, affecting around 
30% patient with DM worldwide. Earliest change 
seen in diabetic retinopathy is the retinal blood 
barrier damage. This microvascular abnormality 
can lead to capillary occlusion and leakage. 
Furthermore, retinal hypoxia, edema, and 
hemorrhage can occur.6 In this review, we will 
focus more in diabetic neurothropic keratopathy 
(DNK).
DIABETIC PERIPHERAL NEUROPATHY (DPN)
One of the neurologic disorders for DM, 
DPN affects 50% of all diabetics patient.4 
Unfortunately, this complication is often 
recognized in later stage. There are several 
theories proposed to explain the pathogenesis of 
DPN including polyol pathway, accumulation of 
advanced glycosylation end-products (AGEs), 
low levels of growth factors, free radical-
oxidative stress, and immunologic factors.4,7
Well-known pathogenesis of DPN is 
increased polyol pathway flux. Hyperglycemia 
induces activation of intracellular polyol pathway 
causing accumulation of sorbitol. This results in 
decreasing level of protein kinase C and Na/K-
ATPase activity, thus cellular water, electrolyte 
imbalance and oxidative injury can occur.8
Another well-known theory of DM 
pathogenesis is AGEs; products of protein cross-
linking causing damage in cellular structure and 
functions. These byproducts reduce the elasticity 
and increase permeability of blood vessels. 
Furthermore, modified plasma proteins bind 
to receptors for AGEs on cells by inducing the 
production of reactive oxygen species (ROS). It 
might activate several factors causing pathologic 
alteration in gene expression.9
Singh et al10 reported that accumulation of 
AGEs can cause fiber loss in peripheral nerve of 
diabetic human. The formation and accumulation 
of AGEs in peripheral nerve take a major role 
in the development of diabetic neuropathy by 
affecting structural and functional proteins 
as well as indirectly activating receptors for 
AGEs.10 AGEs accumulation is responsible 
for the progression of diabetic keratopathy, but 
it’s not well understood. Shi Long et al11 found 
that AGEs induce apoptosis in retinal pericytes 
and corneal epithelium as suggested by corneal 
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epithelium apoptosis in diabetic rats with AGEs 
accumulation.
ROS also plays important role in DN by 
mediating cellular responses to AGEs. Excessive 
ROS found in DM patients causes retinal pericyte 
apoptosis. Shi Long et al11 hypothesized that 
interaction between AGEs and receptor for 
AGEs (RAGE) might induce intracellular ROS 
generation and activate C-jun N terminal kinase 
(JNK) and p38 mitogen-activated protein kinase 
(MAPK), which play an important role for 
corneal epithelium apoptosis.
There are several growth factors which 
undergo deficiency in diabetes. Nerve growth 
factor, neurotrophins3-5, keratocyte growth factor, 
and transforming growth factor are found in 
corneal epithelium and stroma keratocytes. Those 
factors are necessary for epithelial regeneration 
and repairing the damaged peripheral nerves. 
Diabetes can inhibit neuron regeneration by 
detracting these neurotrophic factors.3
Hyperglycemia also induce the expression 
of inflammatory cytokines of the innate immune 
system, such as IL-1β and TNF-α which have 
an important role in lacrimal gland and cornea 
reepithelization impairment thus their expression 
may lead to corneal nerve alterations and cause 
neurotrophic lesion and dysfunction of feedback 
mechanism that controls tear secretion which 
results in diabetic dry eye.12
CORNEA
The cornea is a transparent and avascular 
connective tissue which serves as a protective 
membrane which light pass on its way to the 
retina. Cornea consists of five layers: epithelium, 
bowman membrane, stroma, descement 
membrane, and endothelium. Cornea is in 
constant state of relative dehydration, called 
deturgesced state.13,14 The endothelium plays 
more important role than the epithelium in 
the mechanism of dehydration. Age, trauma, 
and inflammation can decrease the number of 
endothelial cells. Furthermore, endothelial cells 
have no mitotic activity. Destruction of the 
endothelial cells causes transient edema of the 
cornea and loss of transparency which clears 
when the epithelial cells regenerate.13,14
Corneal sensation is essential for optimal eye 
health. Corneal epithelium is the most densely 
innervated and sensitive epithelium surface of 
the body. Cornea is innervated by ophthalmic 
branch of trigeminal ganglion, while corneal 
stromal nerves comes from the sclera or ciliary 
body. Superficial limbal and subconjunctival 
nerve networks also innervate the epithelium 
with denser central distribution. These sensory 
branches are the nasociliary branch of the 
ophthalmic nerve.15 Corneal nerves produce a 
sensation of pain in humans from mechanical, 
thermal, and chemical stimulation. The corneal 
nerve functionality is assessed by corneal 
sensitivity test.3,16
CORNEAL SENSITIVITY ASSESSMENT
Recent studies have explored corneal 
sensitivity as a potential marker of diabetic 
neuropathy.17 There are two clinical techniques 
that may be used to assess corneal sensitivity: 
Cochet Bonnet (CB) aesthesiometer and non-
contact corneal aesthesiometry (NCCA).18
CB aesthesiometer has been used as a 
standard clinical method for measuring corneal 
sensitivity. The instrument consists of a nylon 
monofilament of constant diameter which can 
give pressure based on its length. The length 
of filament which ellicit a sensation on subject 
represents the corneal touch threshold. This 
method is minimally invasive because it causes 
subclinical microtrauma to the contacted part 
of cornea.9
NCCA is the non-invasive measurement 
of corneal sensitivity, which procedure uses 
controlled pulses of air with variable pressure to 
stimulate the cornea. The corneal nerve sensation 
threshold is measured to a composite stimulus 
outcome consisting of air pressure, tear film 
evaporation, disruption, and cooling.18,19 Pritchard 
et al18 reported that composite scores used to 
evaluate neuropathy such as the neuropathy 
disability score (NDS) have been associated with 
corneal sensitivity when measured using NCCA 
and previously shown that a NCCA reading of 
0.66 millibars or more could be diagnostic of 
neuropathy in type 2 DM patients.
Bikbova et al3 reported that confocal 
microscopy is a non-invasive method for 
quantifying the damage of corneal sensory 
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nerves that can be a marker for diabetic 
neuropathy. In vivo corneal confocal microscopy 
is an established technique which has been 
used as a diagnostic tool with a variety of 
clinical applications in ocular and neurological 
diseases.17 Pirchard et al20 reported that a 4-year 
incident neuropathy of type 1 diabetic patient 
that confocal microscope could predict the 
development of DPN with 63% sensitivity and 
74% spesificity.21,22
MEASUREMENT OF NEUROPATHY
Neuropathy can be measured by some 
methods, including diabetic neuropathy 
symptom score, modified neuropathy disability 
score (NDS), neuropad, monofilament, 
electrophysiology, or quantitative sensory 
testing. The diabetic neuropathy symptom score 
is usually used in clinical setting, such as four 
questions regarding steadiness in walking and 
lower limb symptoms. A score between 0 and 
4 are recorded; 0 means there is no neuropathy 
and 4 means polyneuropathy present. The 
modified NDS is a clinical scoring system 
which uses a 128 Hz turning fork, neurotip for 
pin prick sensation, warm and cold metal rods 
for temperature perception, and tendon hammer 
for the presence or absence of ankle reflex. The 
monofilament test using 10-gram nylon filament 
can be used by applying the tip of it to three 
pre-determined points on the sole of the hand 
and foot. Toronto criteria is used to determine 
classification of neuropathic status and with 
either a modified NDS >2 or diabetic neuropathy 
symptoms score >1 which indicates the presence 
of diabetic neuropathy.17,23
Symptoms of neuropathy have also been 
shown to be associated with a loss of corneal 
sensitivity. More recently, the neuropathy 
symptom score was shown to be significantly 
associated with corneal sensitivity, such that 
the greater the symptom score the higher the 
non-contact corneal aesthesiometric sensation 
threshold.18 A direct relationship between corneal 
sensitivity and a comprehensive inventory 
of parameters of neuropathy has not been 
investigated. As the corneal sensation threshold 
measured using NCCA is being explored as 
an additional non-invasive tool in diagnosing 
neuropathy, it is important to understand the 
relationship between corneal sensitivity and 
other measurement of neuropathy.
ALTERED CORNEAL SENSITIVITY AS A 
FORM OF DPN
Corneal sensitivity can be impaired by 
number of ocular and systemic diseases, such 
as DM. Its impairment is found in nearly 20% 
of diabetic patients.23 Pritchard et al18 reported 
that corneal sensation threshold was significantly 
higher for patients with neuropathy compared to 
those without neuropathy and controls (p=0.002). 
It was measured by several functional measures 
of neuropathy, such as NCCA, NDS, neuropad, 
monofilament, DNSS, and others. Patients 
with neuropathy showed poorer outcome of 
established neuropathy measures than diabetic 
patients without neuropathy and control. 
Komolafe et al4 reported there was a strong, 
statistically significant negative correlation 
between corneal sensitivity and vibration 
pressure threshold (peripheral neuropathy). 
Corneal sensitivity decreases significantly with 
the increase in vibration pressure threshold 
(p<0.001). 
Many studies have shown that one of the 
functions of corneal nerve fibers is to maintain 
a healthy cornea.3 Besides, nerve-derived 
trophic factors have functions in regulating 
the biochemistry of the corneal epithelium 
and controlling the normal as well as renewal 
processes in maintaining the corneal epithelial 
cells. Hence, patients with impaired corneal 
innervation, such as in diabetic patients, have 
increased risk of corneal impairment caused by 
trophic factors deficiency. One of manifestation 
of diabetic polyneuropathy in cornea is diabetic 
neurotrophic keratopathy.
Zhou et al24 discovered that impaired corneal 
epithelial wound healing in diabetes can be 
caused by low level of corneal nerve trophic 
factors. In their study using quantitative PCR 
and ELISA, the cilliary neurotrophic factor 
(CNTF) mRNA and protein levels were found 
to be significantly downregulated in diabetic 
mice. They found that low level of CNTF 
causes delayed corneal epithelial wound healing. 
Supplementation of the exogenous trophic 
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factors can promote wound healing by activating 
corneal epithelial stem cells.24
Gao et al25 considered that DM damaged the 
neural communications of dendritic cells and 
impaired sensory nerve regeneration resulting 
in diabetic neuropathy. Diabetic-induced 
denervation of the cornea, damage the integrity 
of corneal epithelial cells and their ability to 
recover from injury. DM decreases the density 
of sensory nerve fibers and the number of CD 
IIC-positive cells in the cornea. They found 
decreased number of dendritic cells is in tune 
with a decrease nerve fibers density. DM impairs 
communication between dendritic cells and 
nerve causing diabetic peripheral neuropathy, 
delayed cornea wound healing, impairs and 
reduces number of dendritic cells infiltration. 
This results in low level of CNTF which has a 
vital role in corneal innervation.25
Diabetic neuropathy may be involved in 
the progression of lacrimal gland dysfunction 
leading to dry eye syndrome. Integrity of 
lacrimal function unit and normal function 
cornea is maintained by nerve fibers. The result 
of Schirmer’s I Test and corneal sensitivity 
were worse in diabetic patients with neuropathy 
compared to patients without neuropathy and 
control (P<0.001).26
Delayed epithelial wound healing and 
lacrimal gland dysfunction may be the cause of 
recurrent erosions. Reduced corneal sensitivity 
plays an important role on dry eye, thus 
predispose to corneal trauma and neurotrophic 
corneal ulcers. Recurrent epithelial defects 
and abrasion were also found in intraocular 
surgeries of diabetic patients. Accumulation of 
AGEs impairs epithelial basement membrane 
and causes delayed re-epithelialization. Thus, it 
causes prolonged and recurrent epithelial defects 
and predispose the cornea to infection, such as 
fungal keratitis.27
Normal post-cataract surgery patients 
with impaired corneal sensitivity is associated 
with impairment of normal blinking and 
tearing reflexes resulting in corneal epithelium 
impairment. In addition, inflammatory cytokines 
produced as a response to corneal incision 
healing may also decrease corneal sensitivity 
and cause tear film instability. Sitompul et al28 
reported that temporal site corneal incision may 
reduce corneal sensitivity in the surgical area 
because it may cut the base of corneal nerves.
Those effects are augmented in patients with 
diabetic keratopathy and decreased corneal 
sensitivity.29 Jiang et al29 found that dry eye 
syndrome was higher in diabetic patients at seven 
days and one month after cataract surgery, which 
predispose them to infection post-surgery, such 
as endopthalmitis.
Pitchard et al18 studied corneal confocal 
microscopy and corneal sensitivity assessment as 
non-invasive techniques to detect early changes 
for diabetic neuropathy. Many studies showed 
that the greater deficits in the neuropathy, the 
poorer the corneal sensitivity is.18,22,30 Those 
findings show that corneal sensitivity does 
become a part of polyneuropathy in DM. 
Bikbova et al3 reported there were a relationship 
between corneal neuropathy and systemic 
neuropathy from clinical and electrophysiology 
test of neuropathy.
MANAGEMENT
Diabetic neurotrophic keratopathy is a 
challenging condition because of its complex 
management .  Pathogenet ic-or ienta ted 
pharmacological treatment for neurotrophic 
keratopathy is not yet available. There are only 
supportive treatment such as artificial tears, 
topical antibiotics, bandage contact lenses, 
amniotic membrane transplantation, or a 
conjunctival flap to treat neurotrophic corneal 
ulcers.17,25
Corneal stem cells are likely associated with 
corneal wound healing. Kramerov et al31 reported 
that there was a significant decrease of stem cell 
number in the corneo-limbal epithelium causing 
delayed wound healing in diabetic patient. 
Limbal stem cells are regulated by environmental 
signals, cytokines, growth factors, and their 
interaction.32
There are numbers of studies exploring 
cytokines and growth factors that may contribute 
in activation and proliferation of corneal stem 
cell. Duan et al33 studied the effect of pluripotin, 
an activator of embryonic stem cell self-renewal, 
in promoting rabbit limbal epithelial cells 
proliferation by improving the in vitro limbal 
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stem/progenitor cells. Pluripotin may be a good 
alternative to improve the expansion of limbal 
stem/progenitor cells. Ho et al34 studied the 
pigment epithelial-derived factor (PDEF) as a 
promotor self-renewal of limbal stem cell. PDEF 
and its fragment facilitate corneal wound healing 
by enhancing limbal stem cell proliferation 
in vitro. PEDF also has mitogenic effect by 
induction of p38 MAPK and signal transducer 
and activator of transcription 3 (STAT3).
Ciliary neurotrophic factor (CNTF) is 
another neuroprotective cytokine which is 
important in neurogenesis and regulation of 
neural stem cells. Zhou et al24 studied CNTF 
and found several functions in cornea epithelial 
cells. CNTF can promote corneal epithelial 
wound healing; corneal healing in CNTF-
treated mice is 48 – 72 hours faster than control. 
CNTF stimulated the colony-forming efficiency, 
the mitogenic activity, and upregulated the 
expression levels of corneal epithelial stem/
progenitor cells-associated transcription factors. 
These give a promising future agent that can 
be used to prevent complication in patient with 
diabetic neurotrophic keratopathy.17,31
CONCLUSION
Corneal sensitivity which is correlated 
with diabetic neuropathy and impaired corneal 
sensitivity may serve as a potential marker 
of diabetic neuropathy. Doctors, especially 
ophthalmologists and internists, should anticipate 
the possibility of observing the following 
changes in diabetic patients with neuropathy by 
using corneal sensitivity assessment test. Further 
study needs to be conducted to investigate 
progenitor/stem cells as a promising agent to 
cure diabetic keratopathy. 
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